Xeris Biopharma Holdings Inventory

Xeris Biopharma Holdings (0A8E.L) currently reports a inventory of $81M as of June 2026. That compares with $67M in the prior-year period — up 20.3% year over year. Use the charts on this page to explore Xeris Biopharma Holdings's inventory history and peer comparisons.

Xeris Biopharma Holdings's inventory increased from $67M to $81M — a 20.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Xeris Biopharma Holdings reported $81M in inventory as of June 2026. That compares with $67M in the prior-year period — up 20.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $81M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Xeris Biopharma Holdings, and consider following 0A8E.L for alerts when major investors trade the stock.

Xeris Biopharma Holdings is classified in the Healthcare sector. On inventory, it currently shows $81M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 0A8E.L with unrelated industries.